基本信息:
- 专利标题: 制御性T細胞の活性を制御する方法および組成物
- 专利标题(英):Method for controlling activity of regulatory t cells and compositions
- 申请号:JP2004535888 申请日:2003-08-29
- 公开(公告)号:JPWO2004024174A1 公开(公告)日:2006-01-05
- 发明人: 洋 珠玖 , 洋 珠玖
- 申请人: 株式会社イミュノフロンティア
- 专利权人: 株式会社イミュノフロンティア
- 当前专利权人: 株式会社イミュノフロンティア
- 优先权: JP2002254967 2002-08-30
- 主分类号: A61K39/00
- IPC分类号: A61K39/00 ; A61K48/00 ; A61K35/76 ; A61K38/00 ; A61K38/17 ; A61K38/20 ; A61K38/21 ; A61P11/00 ; A61P13/12 ; A61P35/00 ; A61P37/00 ; A61P37/02 ; A61P37/06 ; A61P37/08 ; A61P43/00
The present invention provides compositions and control method for controlling the activity of regulatory T cells. CD4 + CD25 + compositions and the composition of regulatory T cells comprising an expression vector encoding an antigen or antigens recognized relates to a method of controlling the immune response by administering to a mammal a mammal, autoimmune prevention and treatment of diseases and allergic diseases, and provides a useful means for suppressing rejection and graft-versus-host reactions in transplantation. Further immunosuppressed state is released by combined administration of the administration of interferon gamma, or interleukin 12 and interleukin 18. In other words, by combining the sensitization by the action and SEREX antigen such cytokines appropriately, regulatory T cells artificially can operate, autoimmune diseases, reactions associated with organ transplantation, allergic reactions and tumor immunity it can be applied to a control.
信息查询:
EspacenetIPC结构图谱:
A | 人类生活必需 |
--A61 | 医学或兽医学;卫生学 |
----A61K | 医用、牙科用或梳妆用的配制品 |
------A61K39/00 | 含有抗原或抗体的医药配制品 |